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Abstract  To  date,  analysis  of  the  vascularisation  of  breast  lesions  mainly  relies  on  MR  imag-
ing. However,  the  accessibility  of  MRI  is  sometimes  limited  and  has  led  to  the  development
of new  means  of  imaging,  such  as  dual-energy  contrast-enhanced  mammography,  which  pro-
vides data  on  the  vascularisation  of  the  breast  along  with  the  usual  morphological  information.
The purpose  of  this  paper  is  to  present  this  new  imaging  technique  as  well  as  the  recent  ref-
erences, illustrated  by  clinical  reports  derived  from  our  everyday  practice  to  focus  on  the
advantages  and  disadvantages  of  this  new  breast  exploration.  Dual-energy  contrast-enhanced
mammography  is  a  recent,  seemingly  promising  technique,  in  the  management  of  breast  can-
cer. The  main  advantages  consist  of  its  easy  installation,  the  good  tolerance  and  the  comfort  in
the interpretation  of  difﬁcult  to  read  mammograms.  However,  the  indications  and  the  role  of
dual-energy  contrast-enhanced  mammography  still  have  to  be  determined  within  the  diagnos-
tic strategy  of  breast  tumours.  New  studies  are  expected,  especially  to  compare  dual-energy
contrast-enhanced  mammography  with  breast  MRI.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.Digital  radiology  has  fostered  the  emergence  of  multiple  innovations  in  breast  exploration.
Until  now,  MRI  was  the  main  technique  used  on  a  routine  basis  to  study  the  enhancement
of  breast  lesions.  However,  problems  related  to  the  accessibility  of  MRI  may  delay  the  care
of  patients  with  breast  cancer.
∗ Corresponding author. Centre Hospitalier d’Armentières, Centre d’imagerie de la femme, 112, rue Sadi-Carnot, 59280 Armentières,
France.
E-mail address: sammy.badr@etu.univ-lille2.fr (S. Badr).
2211-5684/$ — see front matter © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
http://dx.doi.org/10.1016/j.diii.2013.10.002
2t
w
T
e
i
l
f
R
e
a
c
c
T
m
C
o
t
a
t
m
T
m
T
t
e
b
o
o
e
e
[
m
t
c
w
c
l
4
[
F
a
D
I
e
s
b
v
‘
o
i
d
h
t
V
c
N
e
f
e
s
d
l
o
r
i
a
o
m
r
l
s
p
w
I
p
w
s
t
p
contrast-enhanced  mammography  with  the  mammogra-
phy  ±  ultrasound  scan  used  in  routine  clinical  practice46  
Contrast-enhanced  mammography  is  an  angiography
echnique  using  digital  subtraction  applied  to  the  breasts.  It
as  ﬁrst  mentioned  in  1985  in  the  work  by  Watt  et  al.  [1,2].
his  imaging  technique  has  been  found  to  be  interesting  in
rasing  the  normal  mammary  gland  on  subtracted  images
n  order  to  frame  breast  tumours  and  visualise  their  vascu-
arisation.  The  ﬁrst  machines  have  been  marketed  recently,
ollowing  the  clinical  studies  carried  out  at  Institut  Gustave-
oussy  [3—6].
After  a  technical  presentation  and  a  review  of  the  lit-
rature  on  contrast-enhanced  digital  mammography,  this
rticle  will  present  different  aspects  of  the  dual-energy
ontrast-enhanced  technique  that  may  be  encountered  in
linical  practice.
echnical focus on contrast-enhanced
ammography
ontrast-enhanced  mammography  is  based  on  the  principle
f  digital  subtraction  between  2  images:  one  image  con-
aining  information  about  breast  vascularisation,  the  other
bout  its  morphology.  The  post-processing  carried  out  on
hem  reveals  the  ‘‘hyper-vascularised’’  regions  of  the  mam-
ary  gland  by  freeing  itself  from  its  ﬁbroglandular  tissue.
emporal subtraction contrast-enhanced
ammography
he  hyper-vascularised  appearance  of  invasive  malignant
umours  was  emphasised  since  the  ﬁrst  work  on  contrast-
nhanced  mammography  [7].  However,  the  distinction
etween  benign  and  malignant  tumours  cannot  be  based
n  this  aspect  only.  Like  MRI,  the  temporal  monitoring
f  the  breast’s  enhancement  was  studied  to  underline
nhancement  curve  proﬁles  (for  example,  a  progressive
nhancement  proﬁle  is  more  often  found  with  benign  lesions
8,9]).
Therefore,  the  ﬁrst  method  of  contrast-enhanced  mam-
ography  analysed  a  single  speciﬁc  incidence  at  different
imes  after  injection.  The  ﬁrst  image  without  injection  of
ontrast  agent  was  used  as  a  mask.  The  opaciﬁed  images
ere  then  digitally  subtracted  from  the  mask  to  produce  the
ontrast-enhanced  mammography  images  and  only  under-
ine  the  vascularised  structures.  According  to  the  authors,
 to  7  acquisitions  were  carried  out  each  60—120  s  (Fig.  1)
8,10—12].
igure 1. Principle of contrast-enhanced mammography using the t
cquisitions are obtained at a rhythm of one image every 60 to 120 s [8,
[
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ual-energy contrast-enhanced mammography
n  2003,  Lewin  et  al.  mentioned  dual-energy  contrast-
nhanced  mammography  as  an  alternative  to  the  temporal
ubtraction  technique  [13]. Based  on  the  interaction
etween  X-rays  and  iodine,  it  is  possible  to  distinguish
ascular  structures,  saturated  by  contrast  agent,  by  a
‘high  energy’’  image  (beyond  the  attenuation  coefﬁcient
f  iodine,  that  is  Kiodine =  33.2  keV)  and  the  morphological
nformation  by  a  ‘‘low  energy’’  image  (below  Kiodine).  The
igital  subtraction  of  these  2  images  only  underlines  the
yper-vascularised  structures  (Fig.  2a),  as  the  temporal  sub-
raction  technique  does.
alue and validity of dual-energy
ontrast-enhanced  mammography
o  clinical  study  could  demonstrate  a  signiﬁcant  differ-
nce  between  the  enhancement  kinetics  proﬁles  observed
or  malignant  and  benign  lesions.  Therefore,  contrast-
nhanced  digital  mammography  based  on  the  temporal
ubtraction  technique  gave  way  to  the  advantages  of  the
ual-energy  technique  [8,10].  While  the  temporal  method
imited  the  examination  to  only  one  breast  and  only
ne  incidence,  dual-energy  contrast-enhanced  mammog-
aphy  can  be  used  to  study  and  compare  both  breasts,
n  multiple  incidences,  with  a  better  patient  toler-
nce.
The  main  clinical  study,  carried  out  by  Dromain  et  al.,
n  120  patients,  compared  dual-energy  contrast-enhanced
ammography  with  mammography  alone  or  with  mammog-
aphy  alongside  ultrasound  scan  in  the  search  for  malignant
esions  [4].  This  work  demonstrated  a  signiﬁcant  increase  in
ensitivity  for  dual-energy  contrast-enhanced  mammogra-
hy  (93%)  when  compared  with  mammography  alone  (78%),
ithout  a  reduction  in  the  speciﬁcity  (assessed  at  63%)  [4].
n  this  study,  dual-energy  contrast-enhanced  mammogra-
hy  did  not  provide  an  increase  in  diagnostic  performance
hen  compared  with  the  mammography  and  ultrasound
can.
In  view  of  these  ﬁrst  encouraging  results,  the  same
eam  carried  out  a  second  clinical  trial  on  the  same
opulation  to  assess  the  complementarity  of  dual-energyemporal subtraction technique. According to the author, 4 to 7
10—12].
3].  This  demonstrated  an  increase  in  diagnostic  perfor-
ance  by  the  6  readers  (area  under  the  curve  signiﬁcantly
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Figure 2. Principle of dual-energy contrast-enhanced mammography. a: formation of an image in dual-energy contrast-enhanced mam-
mography according to the digital subtraction method. The post-treatment result reveals structures greatly absorbing high energy X-rays,
like the vessels saturated with iodine contrast agent. It should be noted that the high energy images are not directly accessible on the
consoles; b: dual-energy contrast-enhanced mammography protocol.
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ehigher  with  the  help  of  dual-energy  contrast-enhanced
mammography:  0.87  vs  0.83,  P  =  0.045),  as  well  as  a
better  detection  of  additional  malignant  lesions  (sensi-
tivity:  78%  vs  71%,  P  =  0.006)  without  an  increase  in  the
number  of  false  positives.  The  visibility  of  the  lesions
was  similar  or  better  with  the  mammography  ±  dual-energy
contrast-enhanced  mammography  when  compared  to  the
mammography  ±  ultrasound  scan  in  at  least  80%  of  the
cases.
A  recent  preliminary  study  carried  out  by  Jochelson
et  al.  compared  dual-energy  contrast-enhanced  mammog-
raphy  with  breast  MRI.  While  the  2  techniques  seem  to
be  equivalent  in  terms  of  the  global  detection  of  primary
tumours,  the  MRI  would  seem  to  detect  additional  ipsilat-
eral  lesions  better.  However,  the  speciﬁcity  of  dual-energy
contrast-enhanced  mammography  turns  to  be  higher  with  a
lower  proportion  of  false  positives.  Moreover,  the  positive
predictive  value  of  malignity  of  an  enhanced  lesion,  in  the
population,  was  higher  with  dual-energy  contrast-enhanced
mammography  than  with  MRI  (97%  vs  85%,  P  <  0.01)  [14].
i
b
(ractical focus on dual-energy
ontrast-enhanced mammography
xamination protocol
fter  installing  the  patient,  1.5  mL/kg  of  contrast  agent
Omnipaque® (iohexol)  with  an  iodine  concentration  of
00  mg/mL)  are  administered  using  an  automatic  intra-
enous  injector  if  there  are  no  contraindications.  Two
inutes  after  the  injection,  a  medio-lateral  oblique
iew  and  then  a  cranio-caudal  view  are  obtained
n  the  ‘‘non-pathological’’  breast.  The  ‘‘pathological’’
ontra-lateral  breast  is  then  studied  in  the  cranial-
audal  and  then  medio-lateral  images.  There  is  a
ause  of  one  minute  between  images  (Fig.  2b).  The
rotocol  may  be  stopped  if  the  dual-energy  contrast-
nhanced  mammography  is  ‘‘normal’’  (Fig.  3a).  If  there
s  an  anomaly,  the  examination  may  be  completed
y  a latero-medial  and/or  a spot  compression  view
Fig.  3b).
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Figure 3. a: normal dual-energy contrast-enhanced mammography (inside left medio-lateral oblique and cranio-caudal view): absence of
pathological enhancement. White arrow: vessels; black arrow: diffuse matrix enhancement; b: cranio-caudal view with spo compression in
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standard mammogram (on the left) and dual-energy contrast-enhanc
ith regular contours (black arrow) not clearly visible with standar
ain situations encountered in clinical
ractice
ocoregional  metastasis
reast  cancers  are  intensely  enhanced  with  hazy  or
piculated  contours  in  dual-energy  contrast-enhanced  mam-
ography,  as  opposed  to  the  rest  of  the  mammary  gland  that
s  little  or  not  at  all  enhanced  (Fig.  4).
When  breast  cancer  is  clinically  or  radiologically  sus-
ected,  dual-energy  contrast-enhanced  mammography  may
e  useful  to  detect  multiple  homo-  or  contra-lateral  can-
ers,  with  the  injection  of  a  contrast  agent  that  helps
eveal  lesions  that  are  not  spontaneously  visible  by  standard
ammograms  (Fig.  5)  [5,6].  Dual-energy  contrast-enhanced
e
u
Pammography (on the right) of the left breast: nodular enhancement
mmogram: ﬁbroadenoma.
ammography  also  facilitates  the  ultrasound  study  of  mul-
iple  lesions  both  to  better  detect  them  and  also  to  more
asily  decide  on  those  that  require  a  biopsy.
In  the  main  study  by  Dromain  et  al.  assessing  the  efﬁ-
iency  of  dual-energy  contrast-enhanced  mammography  in
reast  cancer  in  120  patients,  the  sensitivity  is  higher  with
ual-energy  contrast-enhanced  mammography  (93%)  than
ith  mammography  alone  (78%)  (P  <  0.01)  without  a  loss  of
peciﬁcity  (63%  vs  58%  with  mammography,  P  =  0.64)  [4].
owever,  there  is  no  signiﬁcant  difference  concerning  the
ensitivity  and  speciﬁcity  between  dual-energy  contrast-
nhanced  mammography  and  mammography  plus  breast
ltrasound  scan  (90%  sensitivity,  P  =  0.72;  47%  speciﬁcity,
 =  0.08).
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Figure 4. A 65-year-old woman with invasive ductal carcinoma initially consulting for a right retroareolar breast mass with permeation
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‘nodules. On the right, images by dual-energy contrast-enhanced 
retroareolar enhancement opposite a clinical lesion and a suspect m
Compared  with  MRI  that  has  a  sensitivity  between  89%
and  96%  according  to  the  histological  type,  dual-energy
contrast-enhanced  mammography  seems  to  provide  the
same  range  of  results  [15].  However,  other  studies  are
required  in  order  to  compare  MRI  and  dual-energy  contrast-
enhanced  mammography.
The  case  reported  in  Fig.  6  illustrates  the  difﬁculty
in  standard  mammography  in  assessing  correctly  the  posi-
tion  of  the  tumour  compared  with  the  nipple  due  to  an
architectural  disorganisation  whose  limits  are  poorly  vis-
ible,  and  the  presence  of  a  rounded  retroareolar  breast
mass,  while  the  contrast  enhancement  with  dual-energy
mammography  helps  better  discern  its  extension.  In  this
case,  it  also  reassures  us  about  the  lack  of  enhancement  of
p
f
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Figure 5. Dual-energy contrast-enhanced mammography for a clinica
standard mammogram (top left) shows an architectural disorganisation in
enhanced mammography (top right) reveals multiple enhancements and m
scan (at the bottom) and helps orient the biopsies.mography with cranio-caudal (CC) view show an extensive right
in the standard mammogram. The left breast is normal.
he  rounded  retroareolar  mass  that,  after  anatomopatho-
ogical  analysis,  corresponds  to  a  galactocele  whereas  the
ltrasound  scan  might  have  seemed  worrying  due  to  the
artially  echogenic  and  irregular  nature  of  the  intra-cystic
ontent.
Like  with  MRI,  one  of  the  current  limits  to  locoregional
etastasis  search  with  dual-energy  contrast-enhanced
ammography  is  related  to  the  discovery  of  non-visible
esions  in  mammography  and  ultrasound  scan  even  after
‘second  look’’  examinations  (Fig.  7).  In  this  young  patient
resenting  a  suspicious  ACR5  mass  in  the  right  breast  that  is
ully  visible  by  mammography  and  whose  limits  are  better
istinguished  on  the  subtraction  image  due  to  the  enhance-
ent  of  the  cancer,  a  contra-lateral  lesion  was  discovered
lly detected nodule of the left axillary prolongation. Whereas the
 the left axillary prolongation (white arrow), dual-energy contrast-
ore easily allows for the detection of suspect images in ultrasound
250  S.  Badr  et  al.
Figure 6. A 61-year-old woman consulting for a left retroareolar breast mass. Whereas in the standard mammogram (on the left, medio-
lateral oblique [MLO] view) several structures are superimposed, dual-energy contrast-enhanced mammography (centre) distinguishes the
g row)
r oma
w
u
r
ﬁ
t
c
b
h
P
T
a
g
e
a
m
w
p
o
s
m
v
c
M
D
F
c
nalactocele (white arrow) and invasive ductal carcinoma (black ar
eveals a hypoechogenic nodule (black arrow, invasive ductal carcin
ithout  distinct  translation  in  the  mammography  and
ltrasound  scan.  Dual-energy  contrast-enhanced  mammog-
aphy  then  led  to  an  MRI  and  then  a  biopsy  under  MRI  to
nally  conclude  to  the  discovery  of  a  small  ﬁbroadenoma  in
he  left  breast.  If  biopsies  were  possible  under  dual-energy
ontrast-enhanced  mammography,  the  patient  would  have
een  reassured  more  quickly  and  her  treatment  would  not
ave  been  as  complex.
ost-therapeutic  monitoring
he  scar  tissue  remodelling  after  breast  surgery  often
ppears  as  architectural  distortions  in  standard  mammo-
rams.  The  distinction  between  post-therapeutic  remod-
lling  and  cancer  recurrence  may  prove  to  be  difﬁcult.  The
bsence  of  enhancement  in  dual-energy  contrast-enhanced
A
s
a
c
igure 7. A 38-year-old woman presenting a suspect mass in the righ
ranio-caudal view: suspect ACR5 mass containing microcalciﬁcations in
odular enhancement of the left breast corresponding to a ﬁbroadenom, the only structure enhanced. The ultrasound scan (on the right)
) and a mixed content cystic lesion (white arrow, galactocele).
ammography  may  increase  conﬁdence  when  confronted
ith  images  that  are  difﬁcult  to  analyse  (Fig.  8),  in
articular  in  dense  breasts  (Fig.  9),  even  if  the  usual  radi-
logy  approach  should  not  change  according  to  the  current
tate  of  knowledge.  Dual-energy  contrast-enhanced  mam-
ography  may  help  distinguish  non-vascularised,  or  little
ascularised  ﬁbrotic  tissue  from  a  recurrence  of  breast
ancer  with  an  enhancement  similar  to  that  found  in
RI.
iagnostic  assessment  of  abnormal  imaging  ﬁndings
fter  a  classic  breast  examination  (mammograms  and  ultra-
ound  scan),  probably  benign  lesions  are  often  classiﬁed
s  ACR  or  BI-RADS  3,  especially  due  to  probable  echogenic
ysts.  In  this  situation,  dual-energy  contrast-enhanced
t breast. Dual-energy contrast-enhanced mammography, bilateral
 standard mammography with poorly deﬁned limits. Discovery of
a after macrobiopsy under MR imaging.
Dual-energy  contrast-enhanced  digital  mammography  251
Figure 8. Annual follow-up of a 55-year-old patient with a past history of right breast cancer, treated with a partial mastectomy in 2010.
The clinical examination is normal. The standard mammogram (on the left) is not easy to read, especially due to asymmetric densities. The
 mam
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mnormal spot compressed images and dual-energy contrast-enhanced
mammography  may  help  distinguish  between  a  purely
liquid  cyst  (Fig.  10)  and  a  cystic  lesion  containing  a  tissue
portion  (Fig.  11).  Purely  liquid  lesions  may  directly  be
classiﬁed  as  benign  ACR  or  BI-RADS  2  lesions  without
monitoring,  and  lesions  with  a  solid  component  may  be
directly  classiﬁed  as  ACR  or  BI-RADS  4  in  view  of  a  biopsy
for  a  histological  examination  to  determine  whether  or  not
there  is  an  intra-canal  or  invasive  component  within  the
cyst.
p
m
5mography reassured the patient.
eedback
n  the  Centre  d’imagerie  de  la  femme  at  Hôpital
’Armentières,  we  assessed  our  practice  during  the
rst  6  months  of  use  of  dual-energy  contrast-enhanced
ammography  (beginning  in  December  2011).  Sixty-ﬁve
atients  beneﬁted  from  dual-energy  contrast-enhanced
ammography.  The  mean  age  of  the  population  was
3.8  years  (37—77  years),  52%  of  them  were  menopaused.
252  S.  Badr  et  al.
Figure 9. A 68-year-old woman with a personal antecedent of right breast cancer treated by surgery. The standard mammogram (on
the left) show dense, difﬁcult to analyse breasts. The dual-energy contrast-enhanced mammography images do not reveal enhancement,
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ohich is reassuring. An ultrasound scan is carried out and is normal (
ontrast-enhanced mammography is already reassuring).
mong  the  patients,  32%  presented  a  family  history  of
reast  cancer  and  31%  personal  antecedents  of  breast
ancer.
Out  of  the  75  patients,  37  lesions  were  identiﬁed
mong  32  patients.  Enhancement  with  dual-energy  contrast-
nhanced  mammography  was  observed  in  73%  of  the  cases
n  =  27/37).
Among  the  27  enhancements,  67%  were  malignant
n  =  18/27),  including  13/18  corresponding  to  invasive  duc-
al  carcinoma  (Table  1).  Nine  enhancements  were  benign
33%,  n  =  9/27),  mainly  corresponding  to  ﬁbroadenomas
n  =  4/9).
f
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igure 10. Patient with dense multi-cystic breasts and attenuating 
on the left) and ultrasound scan. Some cysts are ‘‘atypical’’ (bottom r
ortion, with thick walls, multi-loculated cysts. The exam is classiﬁed a
ontrast-enhanced mammography (top right) does not reveal any intra-c
r BI-RADS 2. Dual-energy contrast-enhanced mammography reveals cysodiﬁcation in the radiology procedure even though the dual-energy
Ten  lesions  were  not  enhanced,  with  a  histology  mainly
elated  to  ﬁbroadenomas  (n  =  7/10).  The  only  false  negative
n  this  study  corresponded  to  a  lymphangitic  carcinomatosis.
his  data  was  used  to  estimate  the  95%  sensitivity  and  the
5%  speciﬁcity.  The  positive  and  negative  predictive  values
ere  67%  and  98%,  respectively.
The  main  artefact  found  in  the  series  is  matrix  enhance-
ent  in  35%  of  the  cases  (n  =  26/75).  It  was  pseudo-nodular
or  58%  (n  =  15/26)  and  diffuse  for  42%  (n  =  11/26)  of  them.
he  matrix  enhancement  hindered  the  interpretation  of  the
nhancement  in  4%  of  the  examinations  (n  =  3/26)  since  it
as  potentially  masking.
zones that are difﬁcult to interpret with standard mammograms
ight): echogenic cysts, with ﬂuid level and doubt about a tissular
s ACR or BI-RADS 3 following the ultrasound scan. The dual-energy
ystic enhancement. The exam may therefore be reclassiﬁed as ACR
ts in the form of ‘‘phantom’’ images.
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Figure 11. A 52-year-old woman consulting for mobile induration of the right breast. The ultrasound scan detects an atypical cystic
he D
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Tlesion of mixed content with a non-vascular echogenic portion in t
with standard mammography, reveals an endocystic enhancement (
papilloma. Dual-energy contrast-enhanced mammography helps det
Limits of dual-energy contrast-enhanced
mammography
False negatives in dual-energy
contrast-enhanced mammography
Although  dual-energy  contrast-enhanced  mammography  is
of  interest  in  detecting  hyper-vascularised  lesions,  little  vas-
cularised  tumours  may  not  be  detected.  In  our  series,  we
only  observed  one  false  negative,  corresponding  to  lymphan-
gitis  carcinomatosis  (Fig.  12).
Table  1  Absolute  and  relative  distribution  of  enhance-
ment  observed  in  37  diagnosed  lesions.
Number  Proportion  (%)
Enhancement  10  27%
Fibroadenoma  7*
Microcystic  area  1
Sclerosing  adenosis  1
Lymphangitic  carcinomatosis  1
Enhancement  of  benign  lesions  9  24%
Fibroadenoma  4
Microcystic  area  1
Papilloma 1
Angiomatosis  1
Intramammary  lymph  node  2
Enhancement  of  malignant
lesions
18** 49%
Inﬁltrating  ductal  carcinoma  13
Tubular  carcinoma  2
Mucinous  carcinoma  2
Intramammary  lymph  node  1
* In 6 patients.
** Including 5 patients with multifocal cancer.
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aoppler. Dual-energy contrast-enhanced mammography, associated
). The ultrasound-guided biopsy allows for the diagnosis of benign
ntra-cystic vascularised tissue.
Another  cause  for  the  non-visualisation  of  a  lesion  is
he  limited  ﬁeld  as  with  mammography.  Since  the  deep
ones  and  axillary  areas  are  difﬁcult  to  explore,  dual-
nergy  contrast-enhanced  mammography  does  not  exempt
rom  doing  a full  clinical  examination  and  a  complementary
reast  ultrasound  scan  in  case  of  a  strong  clinical  suspicion.
Moreover,  the  in  situ  study  of  carcinomas  is  poorly  known.
hey  may  also  be  a  source  of  false  negatives  in  dual-energy
ontrast-enhanced  mammography.
alse positives in dual-energy
ontrast-enhanced mammography
ur  series  reported  several  cases  of  enhanced  benign  lesions
33%,  n  =  9/27).  We  observed  2  types  of  ﬁbroadenoma
nhancement:  a  slow  proﬁle,  homogenising  in  late  images,
nd  a  rapid  proﬁle,  in  early  images  (Fig.  13).  This  kinetics
as  also  described  in  MRI  [7,8].  A  complementary  ultrasound
can  can  correct  the  diagnosis  if  the  characteristics  are  typ-
cal.  In  case  of  doubt,  an  ultrasound-guided  biopsy  may  be
arried  out  for  a  sure  diagnosis.
rtefacts
he  main  artefact  encountered  is  matrix  enhancement.
ne  hypothesis  is  that  it  results  from  extrinsic  factors,
uch  as  the  degree  of  compression  of  the  breasts,  and
ntrinsic  factors,  responsible  for  a  diffused,  non-uniform
cattered  radiation  in  the  gland  (Fig.  14a).  Pseudo-nodular
atrix  enhancement  (Fig.  14b)  may  be  the  cause  of  false
ositives  due  to  the  appearance  that  may  seem  to  be  sus-
ect.  In  our  series,  a  small  number  of  examinations  (n  =  3)
ere  potentially  masked  by  matrix  enhancement.  In  these
ases,  dual-energy  contrast-enhanced  mammography  did
ot  provide  any  additional  information  when  compared  to
he  mammography  and  ultrasound  scan.  Motion  blur  may
lso  be  observed  in  case  of  patient’s  movement  between
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Figure 12. A 55-year-old woman with antecedents of total left mastectomy for ductal carcinoma, and surgically treated recurrence on the
scar tissue. A right axillary adenopathy was found in a follow-up PET—CT. The mammograms, dual-energy contrast-enhanced mammography
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aleft) and ultrasound scan are normal while the breast MRI (right) 
iopsies under MRI raised the diagnosis of lymphangitis carcinomato
he  high  and  low  energy  images  (Fig.  14c).  The  radio-opaque
tructures  seem  displaced  with  a  black  edge.  In  case  of
otion  blur,  a  cancer  may  be  expressed  by  a  ‘‘black  car-
inoma’’:  the  enhancement  of  the  cancer  being  masked
y  the  movement  artefacts  (Fig.  14d).  In  this  case,  the
iagnosis  may  be  ‘‘corrected’’  on  the  other  dual-energy
ontrast-enhanced  mammography  incidences  like  on  the
omplementary  mammography  and  ultrasound  examination.
landular dose
he  diagnostic  reference  level  in  digital  mammography,
s  deﬁned  by  Institut  de  Radioprotection  et  de  Sûreté
ucléaire)  (IRSN)  in  October  2011,  is  1.8  mGy  per  image  for
 breast  thickness  of  45  mm  under  compression.
Out  of  the  104  patients  beneﬁting  from  dual-energy
ontrast-enhanced  mammography,  391  images  were  ana-
ysed  (cranio-caudal  and  medio-lateral  views):  the  mean
hickness  of  the  breast  was  56  mm,  the  average  mean  glan-
ular  dose  (MGD)  was  2.65  mGy  per  image  (including  the
ow  and  high  energy),  for  values  ranging  from  1.07  mGy  to
.76  mGy,  and  a  standard  deviation  of  0.78  mGy  (Table  2).
High  energy  acquisitions  account  for  25%  of  the  total  dose
n  dual-energy  contrast-enhanced  mammography  with  an
verage  MGD  of  0.65  mGy  ([0.24—0.83],  standard  deviation
f  0.23  mGy),  vs  2.00  mGy  ([0.84—3.74],  standard  deviation
f  0.58  mGy)  for  low  energy  acquisitions.
The  exposure  of  ‘‘standard’’  digital  mammograms  from
he  same  patient  population  (360  cranio-caudal  and  medio-
ateral  views)  was  analysed:  mean  thickness  of  the  breast  of
d
e
i
Table  2  Average  mean  glandular  dose  (MGD)  measured  in  3
and  360  standard  mammography  images.  The  values  are  in  mil
MGD  
Dual-energy  contrast-enhanced  mammography
High  energy  (HE)  0.65  
Low  energy  (LE)  2.00  
HE  + LE  (1)  2.65  
Standard  mammograms  (2)  1.72  
Ratio  (1)/(2)  1.54ts enhancement without right retroareolar mass. The stereotaxic
7  mm,  average  mean  glandular  dose  of  1.72  mGy  per  image
[0.74—7.82],  standard  deviation  at  0.96  mGy).
The  low  energy  acquisition,  that  provides  a  ‘‘classic’’
ammogram-like  image,  is  16%  higher  in  our  series  than  the
tandard  digital  mammograms  in  terms  of  exposure  (2  mGy
s  1.72  mGy).
The  total  dose  in  dual-energy  contrast-enhanced  mam-
ography  is  therefore  1.54  times  higher  than  the  dose  in
tandard  digital  mammograms  in  our  population  at  Centre
ospitalier  d’Armentières.
rospects for dual-energy
ontrast-enhanced mammography
rom  a  technical  point  of  view,  one  of  the  main  disad-
antages  of  dual-energy  contrast-enhanced  mammography
s  the  current  inability  to  carry  out  biopsies  under  dual-
nergy  contrast-enhanced  mammography  due  to  the  lack
f  a speciﬁc  system  of  stereotaxy.  Therefore,  it  is  neces-
ary  to  carry  out  breast  MRI  and  then  biopsies  under  MRI
ontrol,  of  enhancements  visible  in  dual-energy  contrast-
nhanced  mammography  and  not  found  in  mammograms  or
uring  an  ultrasound  scan.  This  induces  delays  in  the  care
nd  additional  patient  stress.We  had  one  case  of  discrepancy,  detected  with
ual-energy  contrast-enhanced  mammography,  between
nhancement  biopsied  under  MRI  and  a  lesion  initially  seen
n  a  mammogram  (Fig.  15).  It  involved  an  error  in  the
91  dual-energy  contrast-enhanced  mammography  images
liGray.
Interval  (standard  deviation)
0.24—0.83  (0.23)
0.84—3.74  (0.58)
1.07—4.76  (0.78)
0.74—7.82  (0.96)
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Figure 13. Dual-energy contrast-enhanced mammography image of a ﬁbroadenoma. a: ﬁbroadenoma with slow enhancement. The
ﬁbroadenoma (arrow) is better seen in the late dual-energy contrast-enhanced mammography image, 10 min after the injection; b: ﬁbroade-
noma with rapid enhancement (arrow). It should be noticed that the diffuse matrix enhancement prevents a good demarcation of the
ﬁbroadenoma that appears with blurred and irregular contours.
256  S.  Badr  et  al.
Figure 14. Artefacts in dual-energy contrast-enhanced mammography. a: diffuse matrix enhancement (black arrow); b: pseudo-nodular
m ages 
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catrix enhancement (white arrow), associated with ‘‘phantom’’ im
umour that is enhanced after injection on the right side (black ar
iew due to the movement of the patient: black carcinoma (white 
nterpretation  of  the  location  of  the  enhancement  in  MRI.
he  value  of  dual-energy  contrast-enhanced  mammography
hen  compared  to  MRI  is  to  directly  see  the  correspon-
ence  between  the  morphological  anomalies  detected  in
ammography  on  the  low  energy  images  and  the  enhance-
ents  visible  in  the  recombined  images.  This  advantage  of
ual-energy  contrast-enhanced  mammography  over  MRI
e
a
s
Iof cysts (black arrow); c: kinetic blur opposite surgical clips; d: the
, appears black and ‘‘not enhanced’’ in the medio-lateral oblique
).
id  not  avoid  having  the  patient  subjected  to  biopsies
nder  MRI.  If  a  system  of  sterotaxy  under  dual-energy
ontrast-enhanced  mammography  allowed  for  biopsy  of  the
nhancement,  it  would  also  have  been  possible  to  biopsy  the
rchitectural  distortion  at  the  same  time,  under  ‘‘classic’’
tereotaxy  and  thereby,  reduce  the  care  and  patient  anxiety.
n  the  end,  a  benign  angiomatosis  lesion  was  found  for  the
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Figure 15. Screening of a 50-year-old woman without antecedents with a normal physical examination. Inner architectural distortion
visible only on the cranio-caudal side (white arrow). No ultrasound target: an MRI (bottom) is carried out revealing inner enhancement of
amin
cover
iopsi
Rthe left breast (black arrow) biopsied under MRI. The histological ex
mammography carried out after the biopsies under MRI helped ‘‘dis
architectural distortion visible in the ultrasound scan. Stereotaxic b
enhancement  and  a  sclerosing  adenosis  for  the  architectural
distortion.
Conclusion
Dual-energy  contrast-enhanced  mammography  is  an  inter-
esting  technique  for  the  detection  of  tumoral  lesions  and
provides  diagnostic  conﬁdence  when  confronted  with  difﬁ-
cult  to  read  mammograms.  Its  use  as  a  complementary  exam
may  be  of  particular  use,  in  particular,  in  the  assessment
of  the  locoregional  extension  of  breast  cancer.  This  simple
technique  may  be  easier  and  quicker  to  access  than  MRI
if  dual-energy  contrast-enhanced  mammography  spreads.
However,  additional  studies  are  necessary  to  better  spec-
ify  the  indications,  diagnostic  performance  and  its  role  in
the  strategy  for  the  screening  and  care  of  breast  cancer,  in
particular  when  compared  to  MRI.Disclosure of interest
The  authors  declare  that  they  have  no  conﬂicts  of  interest
concerning  this  article.ation concluded to angiomatosis. A dual-energy contrast-enhanced
’’ that the biopsied enhancement in MRI did not correspond to the
es under MRI ﬁnally helped diagnose sclerosing adenosis.
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